Adipose Mesenchymal Stem Cell-Derived Exosomal microRNA-1236 Reduces Resistance of Breast Cancer Cells to Cisplatin by Suppressing SLC9A1 and the Wnt/β-Catenin Signaling

Adipose Mesenchymal Stem Cell-Derived Exosomal microRNA-1236 Reduces Resistance of Breast Cancer Cells to Cisplatin by Suppressing SLC9A1 and the Wnt/β-Catenin Signaling

Zhongming Jia,1,* Huamin Zhu,2,* Hongguang Sun,1 Yitong Hua,1 Guoqiang Zhang,1 Jingru Jiang,1 Xiaohong Wang1 1Department of Thyroid and Breast Surgery, Affiliated Hospital of Binzhou Medical University, Binzhou 256603, Shandong, People’s Republic of China; 2Department of Medical Ultrasonic...

Full description

Bibliographic Details
Main Authors: Jia Z, Zhu H, Sun H, Hua Y, Zhang G, Jiang J, Wang X
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:Cancer Management and Research
Subjects:
breast cancer
cisplatin
resistance
adipose mesenchymal stem cell-derived exosomes
microrna-1236
slc9a1
Online Access:https://www.dovepress.com/adipose-mesenchymal-stem-cell-derived-exosomal-microrna-1236-reduces-r-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/adipose-mesenchymal-stem-cell-derived-exosomal-microrna-1236-reduces-r-peer-reviewed-article-CMAR

Similar Items